Patel; Sachin V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Patel; Sachin V..The latest application filed is for "stabilized formulations of cns compounds".
Company Profile
6.27.30
- Patel; Sachin V. - Derwood MD
- Patel; Sachin V. - Round Lake IL
- Patel; Sachin V - Round Lake IL
Patent Activity
| Patent | Date |
|---|---|
| Stabilized Formulations Of Cns Compounds App 20210322429 - Chang; Rong-Kun ; et al. | 2021-10-21 |
| Stabilized formulations of CNS compounds Grant 11,077,114 - Chang , et al. August 3, 2 | 2021-08-03 |
| N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,647,717 - Akkari , et al. | 2020-05-12 |
| N-Sulfonylated-Pyrazolo[3,4-b]Pyridin-6-Carboxamides and Method of Use App 20190330207 - Akkari; Rhalid ; et al. | 2019-10-31 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20190202823 - Akkari; Rhalid ; et al. | 2019-07-04 |
| Substituted Tricyclics and Method of Use App 20190135827 - Altenbach; Robert J. ; et al. | 2019-05-09 |
| N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,259,810 - Akkari , et al. | 2019-04-16 |
| Stabilized Formulations Of Cns Compounds App 20190060323 - CHANG; Rong-Kun ; et al. | 2019-02-28 |
| Anti-Viral Compounds App 20190015402 - Bellizzi; Mary E. ; et al. | 2019-01-17 |
| Stabilized formulations of CNS compounds Grant 10,149,853 - Chang , et al. Dec | 2018-12-11 |
| Modulators of cystic fibrosis transmembrane conductance regulator protein Grant 10,118,916 - Altenbach , et al. November 6, 2 | 2018-11-06 |
| Anti-viral compounds Grant 10,039,754 - Bellizzi , et al. August 7, 2 | 2018-08-07 |
| Anti-viral compounds Grant 10,028,937 - Bellizzi , et al. July 24, 2 | 2018-07-24 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20180105522 - Akkari; Rhalid ; et al. | 2018-04-19 |
| N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 9,890,158 - Akkari , et al. February 13, 2 | 2018-02-13 |
| Substituted Tricyclics and Method of Use App 20180037587 - Altenbach; Robert J. ; et al. | 2018-02-08 |
| Substituted tricyclics and method of use Grant 9,840,513 - Altenbach , et al. December 12, 2 | 2017-12-12 |
| Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein App 20170305891 - Altenbach; Robert J. ; et al. | 2017-10-26 |
| Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use Grant 9,796,711 - Akkari , et al. October 24, 2 | 2017-10-24 |
| Anti-Viral Compounds App 20170157105 - Bellizzi; Mary E. ; et al. | 2017-06-08 |
| Anti-Viral Compounds App 20170157104 - Bellizzi; Mary E. ; et al. | 2017-06-08 |
| SUBSTITUTED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXYLIC ACIDS AND METHOD OF USE App 20170101406 - Akkari; Rhalid ; et al. | 2017-04-13 |
| N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20170101405 - Akkari; Rhalid ; et al. | 2017-04-13 |
| Novel Compounds For Treatment Of Cystic Fibrosis App 20170100386 - Akkari; Rhalid ; et al. | 2017-04-13 |
| Anti-viral compounds Grant 9,586,978 - Bellizzi , et al. March 7, 2 | 2017-03-07 |
| Substituted Tricyclics And Method Of Use App 20170015675 - Altenbach; Robert J. ; et al. | 2017-01-19 |
| Anti-viral compounds Grant 9,278,922 - Donner , et al. March 8, 2 | 2016-03-08 |
| Anti-viral compounds Grant 9,249,138 - Degoey , et al. February 2, 2 | 2016-02-02 |
| Anti-Viral Compounds App 20150218194 - Bellizzi; Mary E. ; et al. | 2015-08-06 |
| Anti-viral compounds Grant 9,006,387 - Wagner , et al. April 14, 2 | 2015-04-14 |
| Stabilized Formulations Of Cns Compounds App 20150086629 - Chang; Rong-Kun ; et al. | 2015-03-26 |
| Anti-Viral Compounds App 20150087618 - Bellizzi; Mary E. ; et al. | 2015-03-26 |
| Anti-viral compounds Grant 8,937,150 - DeGoey , et al. January 20, 2 | 2015-01-20 |
| Anti-viral compounds Grant 8,921,514 - DeGoey , et al. December 30, 2 | 2014-12-30 |
| Anti-viral Compounds App 20140315792 - Wagner; Rolf ; et al. | 2014-10-23 |
| Anti-viral Compounds App 20140213595 - DEGOEY; David A. ; et al. | 2014-07-31 |
| Stabilized formulations of CNS compounds Grant 8,748,472 - Chang , et al. June 10, 2 | 2014-06-10 |
| Anti-viral compounds Grant 8,691,938 - DeGoey , et al. April 8, 2 | 2014-04-08 |
| Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers Grant 8,669,255 - Li , et al. March 11, 2 | 2014-03-11 |
| Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers Grant 8,648,074 - Li , et al. February 11, 2 | 2014-02-11 |
| Anti-viral compounds Grant 8,546,405 - DeGoey , et al. October 1, 2 | 2013-10-01 |
| SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS App 20130085142 - Li; Tao ; et al. | 2013-04-04 |
| SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS App 20130085141 - Li; Tao ; et al. | 2013-04-04 |
| Anti-Viral Compounds App 20120220562 - DeGoey; David A ; et al. | 2012-08-30 |
| Anti-Viral Compounds App 20120004196 - DeGoey; David A. ; et al. | 2012-01-05 |
| Stabilized Formulations Of Cns Compounds App 20110244042 - CHANG; Rong-Kun ; et al. | 2011-10-06 |
| Anti-Viral Compounds App 20110207699 - DeGoey; David A. ; et al. | 2011-08-25 |
| Anti-Viral Compounds App 20110092415 - DeGoey; David A. ; et al. | 2011-04-21 |
| Anti-Viral Compounds App 20100317568 - DeGoey; David A. ; et al. | 2010-12-16 |
| Anti-Viral Compounds App 20100267634 - Donner; Pamela L. ; et al. | 2010-10-21 |
| Anti-Viral Compounds App 20100160355 - DeGoey; David A. ; et al. | 2010-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 